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Abstract
Purpose:  The  purpose  of  this  study  was  to  retrospectively  evaluate  the  incidence  of  intraperi-
toneal bleeding  and  other  major  complications  of  transjugular  liver  biopsy  (TJLB)  and  analyze
their outcome  and  management.
Materials  and  methods:  The  clinical  ﬁles  of  341  consecutive  patients  who  had  TJLB  were  retro-
spectively analyzed.  There  were  237  men  and  104  women  (mean  age:  51.38  ±  12.8  years;  range:
17—89 years).  All  patients  had  TJLB  because  standard  percutaneous  transhepatic  biopsy  was
contraindicated.  Patients’  ﬁles  were  reviewed  to  search  for  major  and  minor  procedure-related
complications  during  or  immediately  after  TJLB.
Results:  TJLBs  were  technically  successful  in  331/341  patients  (97.07%;  95%CI:  94.67—98.58%).
Major complications  consisted  exclusively  of  intraperitoneal  bleeding  due  to  liver  capsule  per-
foration and  were  observed  in  2/341  patients  (0.59%;  95%CI:  0.07—2.10%).  They  were  treated
using transcatheter  arterial  or  venous  embolization  with  a  favorable  outcome.  The  most  fre-
quent minor  complications  were  abdominal  pain  (35/341;  10.26%;  95%CI:  7.25—13.99%)  and
supraventricular  arrhythmia  (15/341;  4.40%;  95%CI:  2.48—7.15%).  No  cases  of  inadvertent  injury
of the  carotid  artery  were  observed.
Conclusion:  Major  complications  during  TJLB  are  extremely  rare  and  can  be  managed  using
arterial or  venous  embolization  with  a  favorable  outcome.  Our  results  reinforce  the  general
assumption  that  TJLB  is  a  safe  and  well-tolerated  technique.© 2015  Éditions  franc¸aises  de  rad
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itored.  After  TJLB,  the  patients  rested  in  bed  for  24  hours72  
Transjugular  liver  biopsy  (TJLB)  is  used  for  obtaining  high-
uality  histological  samples  from  patients  with  acute  or
hronic  liver  disease  who  have  severe  coagulation  abnor-
alities  or  ascites  for  whom  standard  percutaneous  biopsy
f  the  liver  is  contraindicated  [1—13].  It  is  well-established
hat  in  patients  with  severe  coagulation  abnormalities  or
scites,  standard  percutaneous  liver  biopsy  is  associated
ith  a  high  risk  of  hemoperitoneum,  which  can  be  life-
hreatening  and  even  fatal  [7,11].  To  avoid  these  risks  TJLB
s  a  satisfactory  alternate  option  [2,6,9,14—17].
Biopsy  of  hepatic  parenchyma  via  the  venous  system
educes  the  risks  of  bleeding,  because  the  basic  concept
ehind  TJLB  is  that  this  sampling  technique  is  performed
ithout  penetrating  the  liver  capsule  (i.  e.,  the  capsule
f  Glisson),  which  is  not  perforated  during  the  procedure
1,11,16].  However,  there  were  some  reports  that  described
evere  and  potentially  life-threatening  complications  during
JLB  [1,2,6,8,18].
Although,  in  theory,  the  capsule  of  Glisson  is  not
erforated  during  TJLB,  this  may  happen,  resulting  in
emoperitoneum  of  varying  severity  in  approximately  0.2%
f  the  procedures  [8,11].  In  most  reported  studies,  probably
ecause  of  a  limited  number  of  patients,  there  were  no  cases
f  intraperitoneal  hemorrhage  due  to  TJLB  [13—15,19—21].
o  date,  a  few  studies  have  speciﬁcally  placed  a  spe-
ial  emphasis  on  this  severe  complication  but  the  majority
f  them  did  not  provide  details  regarding  management
2,22,23].  In  addition,  most  of  reported  cases  were  single
ase  reports  so  that  the  actual  incidence  of  this  complication
s  not  well  known  [24,25].
Accordingly,  the  purpose  of  this  study  was  to  retrospec-
ively  evaluate  the  incidence  of  intraperitoneal  bleeding  and
hose  of  other  major  complications  during  TJLB  and  analyze
heir  management  and  outcome.
aterials and methods
atients
his  retrospective  study  was  performed  on  the  medi-
al  records  of  341  consecutive  patients  who  underwent
JLB  using  ultrasonographic  guidance  for  right  internal
ugular  vein  (RIJV)  puncture  and  an  automated  device
Quick-Core,  Cook,  Bloomington,  IN)  for  liver  biopsy  in  our
epartment  between  April  1995  and  September  2014  inclu-
ively.  The  retrospective  data  analysis  was  approved  by  our
eview  board  and  informed  consent  was  obtained  from  all
atients.
There  were  237  men  and  104  women,  with  a  mean  age
f  51.38  ±  12.8  years  (S.D.;  range:  17—89  years).  During  the
ame  period,  ﬁve  patients  who  were  scheduled  to  undergo
JLB  had  thrombosis  of  the  RIJV  as  evidenced  by  duplex
nd  color  Doppler  ultrasonography  and  were  excluded  from
etrospective  data  analysis  because  they  did  not  undergo
JLB.
Percutaneous  liver  biopsy  was  contraindicated  in  all
atients  because  of  severe  coagulopathy  (221/341;  64.81%),
scites  alone  (20/341;  5.86%)  or  both  (100/341;  29.33%).
evere  coagulopathy  was  deﬁned  by  a  prothrombin  time  6  s
reater  than  control  time  or  by  a  platelet  count  <70  ×  109/L.
arked  ascites  was  deﬁned  as  a  large  amount  of  free-ﬂuid
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round  the  liver  as  evidenced  by  ultrasonography  or  com-
uted  tomography  (CT)  of  the  abdomen.
Indications  for  TJLB  were  as  follows:  155/341  patients
45.46%)  had  a  known  viral  hepatitis  and  liver  biopsy  was
erformed  to  determine  if  a  speciﬁc  treatment  was  needed;
44/341  patients  (42.23%)  were  known  alcohol  abusers
nd  liver  biopsy  was  needed  to  evaluate  the  severity  of
he  disease  (n  =  88)  or  to  determine  if  associated  acute
lcoholic  hepatitis  was  present  (n  =  56);  19/341  patients
5.57%)  had  suspected  nonalcoholic  steatohepatitis  (NASH
yndrome),  10/341  patients  (2.93%)  had  suspected  toxic
epatitis,  4/341  patients  (1.17%)  had  suspected  autoimmune
epatitis,  3/341  patients  (0.88%)  had  suspected  hepatic  lym-
homa,  3/341  patients  (0.88%)  had  Wilson  disease,  1/341
atient  (0.29%)  had  suspected  azathioprine-related  nodular
egenerative  hyperplasia,  1/341  patient  (0.29%)  had  sus-
ected  hepatic  tuberculosis,  and  1/341  patient  (0.29%)  had
uspected  hepatic  candidiasis.  No  patients  had  TJLB  because
ntrahepatic  bile  duct  dilatation  contraindicated  standard
ercutaneous  biopsy.
echnique
ll  procedures  were  performed  by  an  experienced  operator
nder  mild  analgesia.  After  local  anesthesia  with  1%  lido-
aine,  the  RIJV  was  punctured  with  an  18-G  needle-catheter
nder  ultrasound  guidance  using  a  7.5-MHz  dedicated  probe.
 9-Fr,  49  cm  long  introducer  (Radifocus,  Terumo,  Tokyo,
apan)  was  placed  in  the  RIJV  using  a  Seldinger  technique
sing  a  0.035-inch  J-tipped  guide  wire  (Angiodyn,  Braun,
elsungen,  Germany).  Catheterization  of  the  right  hepatic
ein  was  performed  with  a  hydrophilic  0.035-inch  angled
uide  wire  (Radifocus,  Terumo)  and  a  5-Fr  end-hole  catheter.
o  conﬁrm  optimal  placement  in  the  right  hepatic  vein,
 quick-check  angiogram  was  obtained  with  10  mL  of  iod-
nated  contrast  material  injected  by  hand.  A  0.035-inch,
80-cm  long  super-stiff  Amplatz  guide  wire  (Boston  Scien-
iﬁc,  Miami,  FL,  USA)  was  used  to  further  introduce  a  curved
igid  7-Fr  catheter  that  was  placed  into  the  right  hepatic
ein.  Finally,  the  18-G,  60-cm  long  Quick-Core  automated
iopsy  device  was  introduced  coaxially  and  liver  biopsy  was
erformed.
TJLB  was  performed  using  intermittent  ﬂuoroscopy  con-
rol  and  electrocardiographic  monitoring.  The  tip  of  the
iopsy  device  was  placed  not  too  close  to  the  liver  capsule
ecause  the  biopsy  system  advanced  the  needle  tip  24  mm
nto  the  liver  parenchyma  when  ﬁred.  The  right  hepatic
ein  was  used  as  the  biopsy  site  in  all  patients  to  better
ontrol  the  distance  between  the  needle  tip  and  the  liver
apsule.  In  patients  with  ascites,  the  location  of  the  capsule
as  estimated  on  ultrasonography  and/or  CT  images  before
JLB.  After  biopsy,  tissue  samples  were  visually  examined  by
he  operator  who  decided  if  another  specimen  and  further
iopsy  was  needed.  Mild  sedation  was  obtained  two  hours
efore  TJLB.  During  the  procedure,  vital  signs  (i.  e.,  cardiac
tatus  and  arterial  blood  pressure),  were  continuously  mon-nd  the  skin  puncture  site  and  the  abdomen  were  clinically
xamined  every  four  hours.  Abdominal  ultrasonography  and
emoglobin  levels  were  performed  only  when  a complication
as  suspected  on  clinical  symptoms.
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Table  1  Complications  in  341  patients  who  underwent  transjugular  liver  biopsy.
Category  Proportions  %  95%CI
Minor  complications
Cervical  hematoma  5/341  1.47  0.48—3.39
Carotid  puncture  0/341  0.00  0.00—1.08
Supraventricular  arrhythmia  15/341  4.40  2.48—7.15
Hypotension  2/341  0.59  0.07—2.10
Abdominal  pain 35/341 10.26 7.25—13.99
Intrahepatic  hematoma 12/341 3.52 1.83—6.07
Arteriovenous  ﬁstula 1/341 0.29 0.01—1.62
Total 70/341 20.53 16.37—25.21
Major  complications
Large  intrahepatic  hematoma  0/341  0.00  0.00—1.08
Intraperitoneal  bleeding  2/341  0.59  0.07—2.10
IVC  perforation 0/341 0.00  0.00—1.08
Atrial  perforation 0/341 0.00  0.00—1.08
Pneumothorax  0/341 0.00 0.00—1.08
Ventricular  arrhythmia 0/341 0.00 0.00—1.08
Total  2/341  0.59  0.07—2.10
No deaths were reported. CI indicates conﬁdence interval. Classiﬁcation was performed according to the Society of Interventional
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Data collection
For  all  patients  qualitative  and  quantitative  variables  were
tabulated  using  a  standardized  data  collection  form.  Orig-
inal  interventional  radiology  reports  were  reviewed  in
consensus  by  two  radiologists  with  extensive  experience  in
TJLB.  Details  of  each  procedure  were  recorded  after  review-
ing  the  interventional  radiology  and  monitoring  data  sheets,
including  details  regarding  the  number  of  needle  passes  and
the  results  of  pathology  reports.
TJLB  was  initially  analyzed  in  terms  of  technical  success
and  technical  failure  depending  on  a  successful  or  a failed
catheterization  of  hepatic  vein  and  satisfactory  or  unsatis-
factory  liver  tissue  sample.
Associated  morbidity  and  mortality  ≤30  days  were  also
documented  by  reviewing  clinical  and  imaging  ﬁles  and  dis-
charge  summaries.
For  all  patients,  interventional  radiology  reports,  clini-
cal  ﬁles  and  discharge  summaries  were  reviewed  to  detect
any  complications  related  to  the  procedure.  Complications
were  categorized  as  major  or  minor  complications  according
to  the  Society  of  Interventional  Radiology  criteria  (Table  1)
[26].
Statistical analysis
Quantitative  data  (continuous)  were  expressed  as  means,
standard  deviation  (S.D.)  and  ranges.  Qualitative  data  were
expressed  as  raw  numbers,  proportions  and  percentages
along  with  their  95%  conﬁdent  intervals  (CIs).Results
TJLB  was  technically  successful  in  331/341  patients  (97.07%;
95%CI:  94.67—98.58%)  and  gross  liver  tissue  specimens
d
h
i
emean  length:  11.1  ±  5.4  [S.D.];  range:  5.0—20.0  mm)  were
btained  in  the  331  patients.  TJLB  failure  was  reported
n  10/341  patients  (2.93%;  95%CI:  1.42—5.33%).  In  nine
atients,  technical  failure  was  due  to  an  acute  angle  (i.  e.,
90◦) between  the  right  hepatic  vein  and  the  inferior  vena
ava.  In  these  patients,  catheterization  of  the  right  hepatic
ein  was  achieved  with  the  5-French  catheter  and  the  super-
tiff  guide  wire.  However,  marked  angulation  did  not  allow
ecuring  the  curved  rigid  7-Fr  catheter  into  the  right  hepatic
ein,  thus  precluding  safe  introduction  of  the  biopsy  nee-
le.  These  nine  patients  had  atrophy  of  the  liver  and  severe
scites  as  evidenced  on  CT  scan.  In  the  remaining  patients,
istopathological  analysis  revealed  that  tissue  sampling  was
btained  from  the  right  kidney.
The  number  of  passes  needed  to  obtain  adequate  hepatic
issue  samples  ranged  from  1  to  4  needle  passes  (mean:
.43  ±  0.49  [S.D.]).  A  single  pass  was  done  in  230/331
atients  (69.49%),  two  passes  were  needed  in  68/331
atients  (20.54%),  three  passes  in  25/331  patients  (7.55%)
nd  four  passes  in  8/331  patients  (2.42%).
Major  complications  consisted  exclusively  of  intraperi-
oneal  bleeding  due  to  liver  capsule  perforation  and  were
bserved  in  2/341  patients  (0.59%;  95%CI:  0.07—2.10%)  with
epatic  cirrhosis  due  to  alcohol  abuse  and  suspected  super-
mposed  acute  alcoholic  hepatitis.  These  two  patients  (one
3-year-old  woman  and  one  40-year-old  man)  experienced
arked  abdominal  pain  during  TJLB  in  association  with  a
rop  (15  and  20  mmHg)  in  arterial  pressure  and  a  rise  (20
nd  20  BPM)  in  cardiac  frequency.  Of  note,  for  both  patients
JLB  was  technically  successful  and  two  needle  passes  were
erformed.  In  both  patients,  a  venous  angiogram  was  imme-
iately  performed  using  the  5-Fr  catheter  placed  in  the  right
epatic  vein  and  showed  intraperitoneal  extravasation  of
odinated  contrast  material  (Figs.  1  and  2).  Transcatheter
mbolization  of  the  intraparenchymal  venous  track  was  thus
574  A.  Dohan  et  al.
Figure 1. Sixty-three-year-old woman with hepatic cirrhosis who had transjugular liver biopsy because of suspected acute alcoholic
hepatitis; a: venous angiogram through the biopsy catheter (arrow) immediately after transjugular liver biopsy shows active, intraperitoneal
extravasation of iodinated contrast material (arrowhead); b: after embolization with torpedoes of gelatin sponge, control venogram through
transjugular catheter (arrow) does not show persisting extravasation; c: control multidetector row computed tomography in the axial plane
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arrow).
erformed  using  torpedoes  of  gelatin  sponge  (Gelitaspon®,
elita  Medical  BV,  Amsterdam,  The  Netherlands)  measur-
ng  1 ×  1  ×  20  mm3.  The  female  patient  was  successfully
reated  using  3  torpedoes  of  gelatin  sponge  and  control
enogram  did  not  show  further  extravasation  (Fig.  1).  Con-
rol  CT  examination  of  the  abdomen  was  performed  and
howed  no  active  bleeding  but  intraperitoneal  accumula-
ion  of  iodinated  contrast  material  that  was  injected  during
JLB,  thus  conﬁrming  liver  capsule  disruption  (Fig.  1).  No
ransfusions  were  required  and  she  recovered  well.  In  the
ale  patient,  venous  embolization  was  performed  using
 torpedoes  and  control  venogram  did  not  show  further
xtravasation.  However,  the  patient  experienced  worsening
p
d
igure 2. Forty-year-old man with hepatic cirrhosis who had transjugu
enous angiogram through the biopsy catheter (arrow) immediately aft
odinated contrast material (arrowhead); b: multidetector raw compute
njection shows active bleeding (arrow). The patient was treated using serihepatic iodinated contrast material (arrowhead) and fresh blood
n  hemodynamic  status  and  received  two  packs  of  red  blood
ells.  CT  examination  was  thus  performed  and  conﬁrmed
ersisting  bleeding  (Fig.  2).  The  patient  was  immediately
reated  with  transcatheter  arterial  embolization  using  5  tor-
edoes  of  gelatin  sponge  (Gelitaspon®) and  one  metallic  coil
laced  in  the  right  branch  of  the  hepatic  artery.  He  received
wo  additional  packs  of  red  blood  cells  and  recovered  well.
n  both  patients  TJLV  allowed  diagnostic  tissue  sampling  and
istopathological  analysis  conﬁrmed  acute  alcoholic  hepati-
is.The  most  frequent  minor  complication  was  abdominal
ain  at  the  liver  biopsy  site  irradiating  to  the  right  shoul-
er  during  the  procedure  that  resolved  spontaneously  within
lar liver biopsy because of suspected acute alcoholic hepatitis; a:
er transjugular liver biopsy shows intraperitoneal extravasation of
d tomography image in the axial plane during the arterial phase of
elective distal embolization of the hepatic artery.
Major  complications  of  transjugular  liver  biopsy  
Figure 3. Thirty-six-year-old man with hepatic cirrhosis who had
transjugular liver biopsy because of suspected acute alcoholic hep-
atitis. Maximum intensity projection reconstructed multidetector
raw computed tomography image in the oblique plane during the
arterial phase of injection shows arteriovenous ﬁstula between seg-
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pmental arterial branch of hepatic artery (arrow) and hepatic vein
(arrowhead) at the biopsy site.
less  than  three  hours  (Table  1).  Abdominal  pain  was  observed
in  35/341  patients  (10.26%;  95%CI:  7.25—13.99%).  Among
these  35  patients,  ultrasonographic  examination  of  the
abdomen  immediately  after  TJLB  showed  self-limited  hyper-
echogenic  area  in  the  right  liver  corresponding  to  the  biopsy
site  in  12  of  them;  this  ﬁnding  in  the  setting  of  a  recent  TJLB
was  considered  as  a  limited  intrahepatic  hematoma.  In  one
of  them,  because  of  a  transient  worsening  in  hemodynamic
status,  abdominal  CT  examination  was  performed  and  dis-
closed  arteriovenous  ﬁstula  at  the  biopsy  site  that  did  not
require  further  treatment  (Fig.  3).
Supraventricular  arrhythmia  was  reported  in  15/341
patients  (4.40%;  95%CI:  2.48—7.15%).  Limited  cervical
hematoma  at  the  RIJV  puncture  site  was  reported  in  5/341
patients  (1.47%;  95%CI:  0.48—3.39%).  Cervical  hematomas
were  further  conﬁrmed  by  ultrasonographic  examination
and  measured  less  than  3  cm  in  diameter.  All  resolved
after  manual  compression  of  15  to  25  minutes.  Other  minor
complications  are  listed  in  Table  1.  No  cases  of  inadvertent
injury  of  the  carotid  artery  were  observed.
Discussion
In  our  retrospective  analysis  of  341  TJLBs,  we  observed  two
major  complications  in  two  patients  that  required  further
treatment,  yielding  a  major  complication  incidence  rate  of
0.59%.  In  both  patients,  subsequent  percutaneous  endovas-
cular  treatment  allowed  controlling  the  bleeding  and  was
followed  by  a  favorable  outcome.  Of  interest,  no  deaths  due
to  this  severe  complication  were  observed  in  our  study  pop-
ulation,  whereas  a  fatal  outcome  has  been  reported  by  other
researchers  [2].
Shin  et  al.  have  reported  an  incidence  of  1.4%  for
intraperitoneal  bleeding  after  TJLB  [22].  In  their  series,  1/65
patient  experienced  intraperitoneal  bleeding  that  required
a
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eadmission  and  red  blood  cell  transfusion  [22].  No  fur-
her  treatment  and  no  embolization  were  needed  [22].  In
nother  study,  Gamble  et  al.  have  reported  4  occurrences
f  intraperitoneal  bleeding  in  four  patients  following  capsu-
ar  perforation  in  a  series  of  461  TJLBs,  yielding  an  incidence
f  0.87%  [6].
Steadman  et  al.  have  reported  four  severe  complications
n  a  series  of  67  patients  who  underwent  TJLB  [21].  Of  these,
ne  patient  experienced  myocardial  ischemia,  two  patients
ad  severe  but  transient  chest  pain  and  in  the  latter  patient,
he  introducer  placed  in  the  RIJV  migrated  to  the  inferior
ena  cava  and  was  retrieved  percutaneously  through  the
ommon  femoral  vein.  In  their  series,  no  cases  of  intraperi-
oneal  bleeding  were  observed  [21].
In  our  study,  the  two  cases  of  intraperitoneal  bleeding
ccurred  immediately  after  TJLB  so  that  continuous  mon-
toring  of  the  hemodynamic  status  during  the  procedure
elped  detect  this  major  and  potentially  life-threatening
omplication.  This  short  delay  between  tissue  sampling  and
linical  worsening  is  consistent  with  previous  reports  that
ndicate  a  delay  of  less  than  3  hours  following  TJLB  [2,24].
owever,  the  bleeding  may  be  delayed  when  it  is  due  to
epatic  artery  pseudoaneurysm  rupture  [24].
Intraperitoneal  bleeding  is  a  rare  complication  of  TJLB.
arly  detection  helps  start  timely  and  effective  manage-
ent.  Our  results  suggest  that  opaciﬁcation  of  the  right
epatic  vein  using  the  biopsy  catheter  allows  detection  of
ntraperitoneal  extravasation,  thus  conﬁrming  capsule  dis-
uption.  Of  note,  some  authors  recommend  opaciﬁcation  of
he  hepatic  vein  to  detect  any  break  in  the  liver  capsule  and
eakage  of  contrast  agent  following  each  needle  pass  [5,8].
n  addition,  as  suggested  by  our  observations,  when  capsu-
ar  perforation  is  visible  plugging  of  the  needle  track  using
elatin  sponge  through  the  transjugular  catheter  should  be
ndertaken  to  obliterate  the  vascular  track  and  stop  the
leeding  with  a  favorable  outcome  [5]. However,  one  must
eep  in  mind  that  it  is  important  to  safely  deposit  the  pled-
ets  of  gelatin  distally  and  into  the  intraparenchymal  portion
f  the  venous  track  to  avoid  unwanted  reﬂux.  It  is  also  pos-
ible  to  use  metallic  coils  via  the  transjugular  catheter  to
o  so  [8]  but  at  the  penalty  of  an  increased  cost.  When  this
imple  and  direct  venous  approach  fails,  arterial  emboliza-
ion  can  be  considered  to  deﬁnitively  stop  the  bleeding  as  it
as  performed  in  one  of  our  patients.
Percutaneous  arterial  embolization  is  an  effective
reatment  for  intraperitoneal  bleeding  secondary  to  percu-
aneous  biopsy  of  the  liver  [27].  Our  results  show  that  this
echnique  can  be  used  also  for  the  treatment  of  intraperi-
oneal  bleeding  due  to  TJLB,  thus  conﬁrming  the  results
btained  by  others  [6].
In  our  study,  we  observed  only  one  case  of  arteriove-
ous  ﬁstula  that  was  diagnosed  with  abdominal  CT.  This
as  a  minor  complication  that  did  not  require  any  spe-
iﬁc  treatment.  It  may  be  hypothesized  that  the  true
ncidence  of  this  minor  complication  in  our  study  was
nderestimated  because  evaluation  of  the  true  incidence
hould  have  needed  performing  CT  examination  to  all
atients  after  TJLB.  However,  arteriovenous  ﬁstula  may  be major  complication  of  TJLB  in  rare  instances  [23]. In  this
egard,  Esposito  et  al.  have  reported  one  case  of  arteriove-
ous  and  arteriobiliary  ﬁstula  with  severe  intraperitoneal
leeding  and  anemia  that  was  successfully  treated  using
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ercutaneous  arterial  embolization  with  a  favorable  out-
ome  [23].
TJLB  is  not  free  from  complications.  In  the  literature,
he  overall  rate  of  complications  of  TJLB  is  estimated
o  7.1%,  consisting  of  minor  complications  (6.5%),  major
omplications  (0.6%)  and  death  (0.1%)  [1,2,8,10,12,18].
n  this  regard,  there  have  been  reported  cases  of  life-
hreatening  intraperitoneal  bleeding  after  laceration  of  the
iver  capsule  during  TJLB  [2,5,6].  Hemoperitoneum  has  been
eported  in  approximately  0.2%  of  all  procedures,  and  is  gen-
rally  due  to  perforation  of  the  capsule  of  Glisson  [6,8,28].
auses  of  mortality  are  almost  exclusively  hemoperitoneum
0.06%)  and  ventricular  arrhythmia  (0.04%)  [2,8].  Of  note,
atal  intraperitoneal  bleeding  secondary  to  capsular  rupture
as  been  described  by  Lebrec  et  al.  and  other  researchers
2,8,29].  Of  interest,  one  must  note  that  this  fatal  compli-
ation  can  occur  during  TJLB  performed  by  well-trained
perators  [2].
The  correlation  between  the  number  of  needle  passes
nd  the  frequency  with  which  complications  occur  remains
ebated.  Lebrec  et  al.  found  that  complications  correlated
ith  an  increase  in  the  number  of  passes  necessary  to  obtain
dequate  hepatic  tissue  samples  [2]  although  others  found
hat  the  occurrence  of  major  complication  did  not  correlate
ith  the  number  of  samples  taken  [9].  In  our  study,  only
wo  needle  passes  were  performed  in  the  two  patients  with
ntraperitoneal  bleeding,  but  this  does  not  allow  drawing
articular  conclusion.
The  overall  failure  rate  of  TJLB  is  estimated  around  3.2%,
ostly  due  to  the  impossibility  to  cannulate  the  hepatic  vein
43.3%)  or  the  jugular  vein  (25.8%)  and  for  multiple  other
auses  [8].  An  acute  angle  of  less  than  90◦ between  the
xis  of  the  inferior  vena  cava  and  the  hepatic  vein  was  the
ost  common  cause  of  failed  TJLB  and  occurs  in  approxi-
ately  1%  of  TJLBs  [8].  Unwanted  renal  sampling  has  also
een  reported  due  to  the  biopsy  device  being  placed  in  the
ight  renal  vein  rather  than  the  hepatic  vein  as  observed  in
/341  patients  of  our  series  [2].
In  our  study,  no  cases  of  inadvertent  puncture  of  the
arotid  artery  were  observed.  As  already  suggested,  this
ay  be  due  to  the  use  of  ultrasonographic  guidance  for
IJV  puncture  [15,30].  The  use  of  ultrasonography  has
een  strongly  recommended  to  avoid  complications  such
s  pneumothorax,  carotid  artery  puncture  and  other  vas-
ular  damages,  which  may  lead  to  life-threatening  and  fatal
nternal  hemorrhage  [15,30].
onclusion
n  conclusion,  TJLB  is  a  simple  procedure  in  the  major-
ty  of  cases.  However,  this  technique  is  not  free  from
omplications.  Besides  minor  complications  that  do  not
equire  speciﬁc  treatment,  liver  capsule  damage  during
JLB  may  lead  to  life-threatening  intraperitoneal  bleeding.
ur  results  demonstrate  that  life-threatening  complications
uring  TJLB  are  extremely  rare.  In  addition,  they  can  be
anaged  using  transvenous  or  transarterial  embolization
ith  a  favorable  outcome.  Our  results  reinforce  the  general
ssumption  that  TJLB  is  a  safe  and  well-tolerated  tech-
ique.
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